Healthtech Startups

Enzo is an AI-native software platform built specifically for home health agencies, unifying intake, scheduling, documentation, OASIS, coding, QA, billing, quality management, and reporting on a single system. It automates routine work and flags cases needing human review, addressing home health workflows such as PDGM, RAP/NOA, and episode-based care.

2 investors

Eolas operates a platform that delivers targeted, evidence-based medical content to healthcare professionals at the point of clinical decision-making. The platform enables pharmaceutical companies, medical device manufacturers, and healthcare organizations to provide relevant educational materials and treatment guidelines to clinicians based on specialty and clinical needs.

2 investors

Eon Aligner manufactures clear dental aligners and provides treatment planning services to dentists, operating primarily in the MENA region. The company serves orthodontists with direct-to-doctor solutions including pre-approved treatment plans and clinical support.

2 investors

EOS imaging provides low-dose 2D/3D imaging systems and software solutions for orthopedic surgery, enabling surgical planning and post-operative assessment. The company serves orthopedic surgeons and healthcare providers across more than 40 countries.

2 investors

Epidarex is a venture capital firm that invests equity in early-stage life science and health technology companies, particularly university spin-outs and startups in under-ventured research hubs across the UK and US. The firm leverages its network of scientists, industry executives, and regulatory experts to support portfolio companies in translating research into commercial healthcare businesses.

2 investors

Epigenica is a life sciences company working in multi-omics, biomarker discovery, and diagnostics. It develops advanced technologies for the life science and healthcare sectors.

2 investors

Epigenic Therapeutics develops gene regulation-based biotherapeutics using its EPIREG platform, which applies AI algorithms to design CRISPR-Cas components that regulate target gene expression without altering the DNA sequence. Combined with a lipid nanoparticle delivery system, the technology targets metabolic, cardiovascular, viral hepatitis, ocular, oncology and rare diseases.

2 investors

Epigno develops management systems for medical and nursing care institutions and provides related consulting services. The company serves healthcare and elderly-care organizations in Japan.

2 investors

Epikast provides AI-powered tools for medical science liaisons and field teams to analyze clinical interactions with physicians and patients, and to access synthesized scientific information in their disease areas. The company serves pharmaceutical and life sciences companies seeking to enhance communication and relationship management with healthcare professionals.

2 investors

Epiliquid develops blood-based molecular tests for cancer detection and differential diagnosis using a platform that combines AI-driven methylation biomarker discovery, patented native-DNA assay chemistry, and PCR-based readout. Its technology measures multiple methylation biomarkers in a single PCR reaction and runs on the qPCR and digital PCR instruments clinical laboratories already use, serving precision oncology.

2 investors

Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium. The company aims to bring early intervention treatment to patients globally.

2 investors

Epitomee develops ingestible therapeutic devices and platforms that deliver targeted therapies along the gastrointestinal tract to manage metabolic diseases, obesity, and deliver biologics. The company combines mechanical and ingestible morphology platforms with therapeutic agents to achieve specific localization with limited side effects.

2 investors

Epsilon partners radiologists with advanced technology to address the radiology shortage in the US and improve diagnostic accuracy and speed. The company combines human expertise with AI to reduce delays in medical imaging, which accounts for 75% of medical decisions.

2 investors

Epsilon Imaging develops EchoInsight, a software platform that uses speckle-tracking strain imaging and automated analysis to detect cardiovascular dysfunction from echocardiograms earlier than traditional methods. The platform combines AI-driven automation with engineered algorithms to help clinicians assess heart function, monitor disease progression, and support clinical decision-making.

2 investors

Erisyon is a biotechnology company that develops technology to advance scientific and health discoveries, building on research from the University of Texas at Austin's Center for Systems and Synthetic Biology. It was founded in 2018 by a group of technologists and entrepreneurs.

2 investors

Clario provides endpoint technologies and software for clinical trial management, serving pharmaceutical and biotech sponsors, CROs, and clinical trial sites globally. The platform combines imaging analysis, electronic clinical outcome assessments, cardiac safety monitoring, and AI-powered solutions to support site-based, hybrid, and decentralized clinical trials.

2 investors

Eruptr provides performance media and paid media services for healthcare organizations, delivered as part of Unlock Health's full-funnel media capability. Its campaigns span search, social, video, streaming, traditional, and recruitment channels to generate qualified leads and integrate them into CRMs and electronic health records.

2 investors

eSight makes a wearable, hands-free digital device that uses a camera and image-processing algorithms to enhance sight for people with central vision loss and legal blindness caused by more than 20 eye conditions. The product offers features such as zoom, contrast, and color filters to help users read, recognize faces, watch TV, and maintain mobility, and it includes a personal coaching program for setup and support.

2 investors

EsoCap AG is a clinical-stage Swiss biotech company developing treatments for esophageal diseases. The company is led by an experienced industry team with clinical development expertise.

2 investors

Esperovax develops oral mRNA vaccines delivered as pills or gummies that synthesize the mRNA in the intestines, where 70% of the immune system resides. The company aims to address production and logistical challenges of traditional mRNA vaccines while improving patient acceptance.

2 investors

Esperto Medical is a medical device company developing compact, sensor-based diagnostic and monitoring technology, drawing on expertise in electrical engineering, imaging, and machine learning. Its work targets continuous physiological monitoring, including blood pressure sensing, for healthcare applications.

2 investors

Essence Healthcare is a Medicare Advantage plan and value-based care provider that partners with doctors to deliver high-quality, affordable care to Medicare beneficiaries while reducing overall healthcare costs. The company operates through technology and partnerships to improve clinical outcomes and member experience.

2 investors

Ethicon develops surgical products and technologies including wound closure, hemostats, surgical stapling, surgical energy, antimicrobial dressings, and surgical instruments, along with clinical education programs for surgeons. Part of Johnson & Johnson MedTech, it serves clinicians and healthcare providers across specialties such as bariatric, cardiovascular, colorectal, gynecology, orthopaedic, and thoracic surgery.

2 investors

Ethnomet is a digital healthcare platform offering telemedicine, remote patient monitoring devices (such as the EthnoRing and Ethno Homecare), virtual care centers, and a practice management system. It serves patients, physicians, healthcare service providers, and resellers, including white-label e-health and e-pharmacy platforms for partners like telecom providers.

2 investors